Medication Supply Disruption

posted Jun 12, 2018, 1:05 AM by Chong Ching Wern   [ updated Jun 12, 2018, 1:05 AM ]
12 June 2018 (Circular No. SP PPUM: 217/2018):

The following medications will be facing supply disruptions:

No.

Name of Medication

Formulary Category

Cause / Action by Pharmacy

Estimated Stock Recovery

Alternative Medication


1)

Fentanyl 100mcg/2mL Injection

Standard Formulary

· Raw material supply issues by Duopharma (M) Sdn. Bhd.

· Pharmacy Department has a balance stock of  about 1500 ampoules only.

August 2018.

Consider use of other medications which are available in our Standard Formulary

2)

Dexamethasone 8mg Injection (For IT use)



Standard Formulary

· Production ceased.

· Raw materials were found not suitable for Intrathecal preparations. 


N/A

Consider use of IT Hydrocortisone Sodium Succinate 25mg/0.5mL Injection prepared by our Manufacturing Pharmacy.

3)

Potassium Dihydrogen Phosphate 10mmol/10mL Injection

Standard Formulary

· Stock supply delivery delay by Pfizer (M) Sdn. Bhd.



Until further notice.

None, Pfizer (M) Sdn. Bhd. is the sole manufacturer of the medication.

4)

Lidocaine 1% Injection


Standard Formulary

· Stock supply issues by Pfizer (M) Sdn. Bhd.

· Remaining stocks will solely be used for cases which require intravenous administration only. 


N/A

Ward stock supplies will be switched to Lidocaine 2% Injection.